Advanced Search


Study ID Status Title Patient Level Data
113750 Active, not recruiting GSK1550188 A 52 week study of belimumab versus placebo in the treatment of subjects with systemic lupus erythematosus (SLE) located in Northeast Asia
113758 Terminated A randomized, open-label, Phase II, 2-arm multi-center trial comparing maintenance therapy with pazopanib or pemetrexed in non-progressing subjects with metastatic stage IVA and IVB non-squamous Non-small Cell Lung Cancer (NSCLC) after induction therapy with carboplatin + pemetrexed or cisplatin + pemetrexed
113761 Completed TZV Epidemiology Program of HSR and Rechallenge HSR: HIV Insight
113762 Completed TZV Epidemiology Program of HSR and Rechallenge HSR: CHORUS
113765 Active, Not Recruiting A Multicenter, Randomized, Double-Blind and Open-label Phase III Study To Compare The Efficacy And Safety Of Eltrombopag With Placebo In Chinese Chronic ITP Patients
113771 Completed A Four-Part, Open-Label Study to Evaluate the Effects of Repeat Dose GSK2118436 on the Single Dose Pharmacokinetics of Warfarin and the Effects of Repeat Dose Oral Ketoconazole and Oral Gemfibrozil on the Repeat Dose Pharmacokinetics of GSK2118436, and the Repeat Dose Pharmacokinetics of GSK2118436 in Subjects with BRAF Mutant Solid Tumors
113773 Completed A Two-Part Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects with V600 BRAF Mutation-Positive Tumors: An Open-label, Dose-escalating Safety Lead-in Study Followed by a Single-sequence, Placebo-controlled, Single-blind Study
113776 Completed A Phase 1 dose escalation study to investigate the pharmacokinetics, pharmacodynamics, safety, and tolerability of single intravenous doses of GSK2315698A in healthy volunteers
113779 Completed A study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of administering multiple oral doses of GSK1292263 alone and with atorvastatin
113782 Completed A Clinical Outcomes Study to compare the effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg with placebo on Survival in Subjects with moderate Chronic Obstructive Pulmonary Disease (COPD) and a history of or at increased risk for cardiovascular disease Study Listed on
113783 Completed A Fixed-Dose Study of Lamotrigine versus Placebo in the Long Term Prevention of Relapse and/or Recurrence of a Manic, Hypomanic, Mixed or Depressive Episode in Adult Subjects with Bipolar I Disorder
113789 Completed A Randomized, Placebo-Controlled, Double-Blind, Four-way Crossover Study to Assess the Effect of Single Oral Doses of Retosiban on Cardiac Repolarization, with Moxifloxacin as a Positive Control in Healthy Volunteers Study Listed on
113794 Terminated A Phase I Open-Label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK2126458 and GSK1120212 Combination Therapy in Subjects with Advanced Solid Tumors.
113797 Completed An open label, multi-centre, non-interventional post-marketing surveillance to monitor the safety and effectiveness of AVODART® administered in Korean androgenetic alopecia patients according to the prescribing information
113806 Completed An open-label, single-arm, Phase I/II study of lapatinib in combination with weekly paclitaxel as first-line chemotherapy for ErbB2-overexpressing Metastatic Breast Cancer patients
113807 Completed Phase IIIb immunogenicity, safety and reactogenicity study of GSK Biologicals’ meningococcal vaccine [GSK 134612] when given as one dose to healthy subjects aged 56 years or older Study Listed on
113808 Completed Efficacy, immunogenicity and safety of two doses of GlaxoSmithKline (GSK) Biologicals' Oral Live Attenuated Liquid Human Rotavirus (HRV) Vaccine (444563), in healthy infants Study Listed on
113809 Completed Immunological non-inferiority between two process-manufactured influenza vaccines in adults aged 18 to 60 years Study Listed on
113810 Terminated Safety and immunogenicity study of GSK Biologicals’ pandemic influenza candidate vaccine (GSK2340272A) in children aged 3 to 9 years Study Listed on
113813 Completed The prevalence of sleep disturbance in patients with parkinson's disease in Korea
113814 Completed Zyban PEM study
113817 Completed Characterisation of healthy volunteers, asthma and Chronic Obstructive Pulmonary Disease patients for inhalation profile, pharyngometry, spirometric indices and lung morphometry
113818 Completed A Phase I, single-center, drug interaction study between simvastatin, atorvastatin, rosuvastatin, and GSK2248761 in healthy subjects.
113819 Completed Safety and Immunogenicity of GSK Biologicals’ Herpes Zoster vaccine 1437173A in healthy ethnic Japanese adults
113834 Completed Differential associations of beta-blockers with hemorrhagic events for chronic heart failure patients on warfarin



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.